Essays on Synuclein

{Author Name [first-name middle-name-initials last-name]} {Institution Affiliation [name of Author’s institute]}

Introduction

Parkinson Disease (PD) is a very complicated neurodegenerative condition including the motor and non-motor manifestations that lead to neuronal loss. Currently, only symptomatic therapies are available but nothing is known yet to prevent this degenerative process. This is a multi-factorial condition with multiple risk factors that includes increasing age, genetic vulnerability, and environmental determinants. All these factors mutually play a role in the pathogenic process of PD. Medical sciences have achieved major advances in understanding the process working behind PD development that are Nigral Dopaminergic Apoptosis, Protein ...

Abstract

This paper is about the investigation of Parkinson’s disease, and in particular is involved with the examination of its symptoms, stages, causes, prevalence, diagnosis and treatment, and social impacts. Finally, the paper analyzes and evaluates two ongoing on Parkinson’s disease researches, which are also examined in respect to their impact on Parkinson’s disease patients. Key words: Parkinson disease, Parkinson disease causes and impacts, Parkinson disease symptoms and prevalence, Parkinson disease diagnosis, and Parkinson disease ongoing research.

Idiopathic Parkinson disease (PD) is a progressively evolving disease with main manifestations resting tremor, muscle stiffness, slow movement and loss ...

Parkinson’s disease is the 2nd most common degenerative disorder after Alzheimer’s disease. It is the most common disorder that affects movement. Its symptoms include tremors while at rest, slowness, stiffness and impaired balance. Progression of the disease may affect speech, walking and the performance of simple tasks. The Progression and the severity of the disease vary from one person to another. While most patients live long productive lives, the disease progresses much faster in other patients leading to disability. About one million people have Parkinson’s disease in the United States and about 5 million around the ...